NO875136L - Heste - gamma - interferon. - Google Patents

Heste - gamma - interferon.

Info

Publication number: NO875136L
Authority: NO; Norway
Prior art keywords: gamma; eqifn; interferon; horses; polypeptide
Prior art date: 1986-12-10

Application number

NO87875136A

Other languages

English (en)

Other versions

NO180239B (no

NO875136D0 (no

NO180239C (no

Inventor

Rudolf Hauptmann

Adolf Himmler

Peter Swetly

Original Assignee

Boehringer Ingelheim Int

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-12-10

Filing date

1987-12-09

Publication date

1988-06-13

1987-12-09 Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int

1987-12-09 Publication of NO875136D0 publication Critical patent/NO875136D0/no

1988-06-13 Publication of NO875136L publication Critical patent/NO875136L/no

1996-12-02 Publication of NO180239B publication Critical patent/NO180239B/no

1997-03-12 Publication of NO180239C publication Critical patent/NO180239C/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/249—Interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/57—IFN-gamma
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Toxicology (AREA)
Immunology (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Saccharide Compounds (AREA)

NO875136A 1986-12-10 1987-12-09 Ekspresjonsvektor som koder for, og kan uttrykke et polypeptid med de biologiske og immunologiske egenskapene til EqIFN-<gamma>, vertsorganisme transformert med denne, og fremgangsmåte for fremstilling av nevnte polypeptid NO180239C (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19863642096 DE3642096A1 (de)	1986-12-10	1986-12-10	Pferde-(gamma)-interferon

Publications (4)

Publication Number	Publication Date
NO875136D0 NO875136D0 (no)	1987-12-09
NO875136L true NO875136L (no)	1988-06-13
NO180239B NO180239B (no)	1996-12-02
NO180239C NO180239C (no)	1997-03-12

Family

ID=6315829

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO875136A NO180239C (no)	1986-12-10	1987-12-09	Ekspresjonsvektor som koder for, og kan uttrykke et polypeptid med de biologiske og immunologiske egenskapene til EqIFN-<gamma>, vertsorganisme transformert med denne, og fremgangsmåte for fremstilling av nevnte polypeptid

Country Status (20)

Country	Link
US (1)	US5602010A (no)
EP (1)	EP0271824B1 (no)
JP (3)	JPS63233794A (no)
KR (1)	KR880007568A (no)
AT (1)	ATE91722T1 (no)
AU (1)	AU616873B2 (no)
CA (1)	CA1339776C (no)
DE (2)	DE3642096A1 (no)
DK (1)	DK170054B1 (no)
ES (1)	ES2058094T3 (no)
FI (1)	FI99116C (no)
HU (1)	HU213566B (no)
IE (1)	IE60404B1 (no)
IL (1)	IL84780A (no)
NO (1)	NO180239C (no)
NZ (1)	NZ222856A (no)
PH (1)	PH30889A (no)
PT (1)	PT86332B (no)
SU (1)	SU1701114A3 (no)
ZA (1)	ZA879245B (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FI88175C (fi)	1980-04-03	1993-04-13	Biogen Inc	Rekombinant-dna-molekyler och foerfaranden foer framstaellning av polypeptider liknande humant -interferon
US6307025B1 (en)	1989-04-28	2001-10-23	Biogen, Inc.	VCAM fusion proteins and DNA coding therefor
US5272263A (en) *	1989-04-28	1993-12-21	Biogen, Inc.	DNA sequences encoding vascular cell adhesion molecules (VCAMS)
US7049102B1 (en)	1989-09-22	2006-05-23	Board Of Trustees Of Leland Stanford University	Multi-gene expression profile
GB9414752D0 (en) *	1994-07-21	1994-09-07	Q One Biotech Ltd	Feline gamma-interferon
GB2291645A (en) *	1994-07-21	1996-01-31	Q One Biotech Ltd	Equine gamma-interferon
AU2587002A (en) *	2000-11-03	2002-05-15	Biomedicines Inc	Method for short-term and long-term drug dosimetry
KR20040053291A (ko) *	2001-11-09	2004-06-23	바이오메디신즈 인코포레이티드	오메가 인터페론을 이용한 질환 치료 방법
US7731947B2 (en)	2003-11-17	2010-06-08	Intarcia Therapeutics, Inc.	Composition and dosage form comprising an interferon particle formulation and suspending vehicle
US11246913B2 (en)	2005-02-03	2022-02-15	Intarcia Therapeutics, Inc.	Suspension formulation comprising an insulinotropic peptide
WO2006083761A2 (en)	2005-02-03	2006-08-10	Alza Corporation	Solvent/polymer solutions as suspension vehicles
MX2008014870A (es)	2006-05-30	2009-02-12	Intarcia Therapeutics Inc	Modulador de flujo para sistema de suministro osmotico con canal interno de dos piezas.
MX2009001114A (es)	2006-08-09	2009-02-10	Intarcia Therapeutics Inc	Sistemas de suministro osmotico y ensambles de piston.
CN104000779A (zh)	2007-04-23	2014-08-27	精达制药公司	促胰岛素释放肽的混悬制剂及其应用
CA2726861C (en)	2008-02-13	2014-05-27	Intarcia Therapeutics, Inc.	Devices, formulations, and methods for delivery of multiple beneficial agents
DK2462246T3 (da)	2009-09-28	2017-11-06	Intarcia Therapeutics Inc	Hurtig etablering og/eller afslutning af væsentlig steady-state-lægemiddelafgivelse
US20120208755A1 (en)	2011-02-16	2012-08-16	Intarcia Therapeutics, Inc.	Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US9889085B1 (en)	2014-09-30	2018-02-13	Intarcia Therapeutics, Inc.	Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
US10925639B2 (en)	2015-06-03	2021-02-23	Intarcia Therapeutics, Inc.	Implant placement and removal systems
MA53353A (fr)	2016-05-16	2021-06-09	Intarcia Therapeutics Inc	Polypeptides sélectifs pour le récepteur du glucagon et méthodes pour leur utilisation
USD840030S1 (en)	2016-06-02	2019-02-05	Intarcia Therapeutics, Inc.	Implant placement guide
USD860451S1 (en)	2016-06-02	2019-09-17	Intarcia Therapeutics, Inc.	Implant removal tool
KR20190104039A (ko)	2017-01-03	2019-09-05	인타르시아 세라퓨틱스 인코포레이티드	Glp-1 수용체 효능제의 연속적인 투여 및 약물의 동시-투여를 포함하는 방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE88622C (no) *
ZA811368B (en) *	1980-03-24	1982-04-28	Genentech Inc	Bacterial polypedtide expression employing tryptophan promoter-operator
ZA831094B (en) *	1982-02-22	1983-11-30	Biogen Nv	Dna sequences,recombinant dna molecules and processes for producing human immune interferon-like polypeptides
IE54592B1 (en) *	1982-03-08	1989-12-06	Genentech Inc	Anumal interferons, processes involved in their production, compositions containing them, dna sequences coding therefor and espression vehicles containing such sequences and cells transformed thereby
DE3247922A1 (de) *	1982-12-24	1984-06-28	Boehringer Ingelheim International GmbH, 6507 Ingelheim	Dna-sequenzen, deren herstellung, diese sequenzen enthaltende plasmide und deren verwendung zur synthese eukaryotischer genprodukte in prokaryoten
JPS60118196A (ja) *	1983-11-30	1985-06-25	Takeda Chem Ind Ltd	インタ−フェロンの製造法
US4666865A (en) *	1984-01-13	1987-05-19	Centocor, Inc.	Immunoassay for biologically active human interferon-gamma employing unique monoclonal antibodies
DE3414831A1 (de) *	1984-04-19	1985-10-31	Hoechst Ag, 6230 Frankfurt	Herstellung von polypeptiden mit human-gammainterferon-aktivitaet
FI90990C (fi) *	1984-12-18	1994-04-25	Boehringer Ingelheim Int	Rekombinantti-DNA-molekyyli, transformoitu isäntäorganismi ja menetelmä interferonin valmistamiseksi
US4689224A (en) *	1985-10-07	1987-08-25	Neogen Corporation	Method for administering vaccines containing equine leukokines and compositions therefor
DE3607835A1 (de) *	1986-03-10	1987-09-24	Boehringer Ingelheim Int	Hybridinterferone, deren verwendung als arzneimittel und als zwischenprodukte zur herstellung von antikoerpern und deren verwendung sowie verfahren zu ihrer herstellung
CA1340698C (en) *	1986-07-25	1999-08-10	Kabushiki Kaisha Hayashibara Seibutsu Kaguku Kenkyujo	Preparation and uses of interferon-gamma
US4908432A (en) *	1987-01-09	1990-03-13	New York University	Novel polypeptide having gamma-interferon activity

1986
- 1986-12-10 DE DE19863642096 patent/DE3642096A1/de not_active Ceased
1987
- 1987-12-08 AU AU82233/87A patent/AU616873B2/en not_active Ceased
- 1987-12-09 EP EP87118264A patent/EP0271824B1/de not_active Expired - Lifetime
- 1987-12-09 DK DK645887A patent/DK170054B1/da not_active IP Right Cessation
- 1987-12-09 ZA ZA879245A patent/ZA879245B/xx unknown
- 1987-12-09 DE DE8787118264T patent/DE3786649D1/de not_active Expired - Fee Related
- 1987-12-09 ES ES87118264T patent/ES2058094T3/es not_active Expired - Lifetime
- 1987-12-09 SU SU874203834A patent/SU1701114A3/ru active
- 1987-12-09 CA CA000553890A patent/CA1339776C/en not_active Expired - Fee Related
- 1987-12-09 NZ NZ222856A patent/NZ222856A/xx unknown
- 1987-12-09 AT AT87118264T patent/ATE91722T1/de not_active IP Right Cessation
- 1987-12-09 IE IE334287A patent/IE60404B1/en not_active IP Right Cessation
- 1987-12-09 HU HU875549A patent/HU213566B/hu not_active IP Right Cessation
- 1987-12-09 NO NO875136A patent/NO180239C/no unknown
- 1987-12-10 PT PT86332A patent/PT86332B/pt not_active IP Right Cessation
- 1987-12-10 JP JP62313130A patent/JPS63233794A/ja active Pending
- 1987-12-10 IL IL84780A patent/IL84780A/xx not_active IP Right Cessation
- 1987-12-10 PH PH36200A patent/PH30889A/en unknown
- 1987-12-10 KR KR870014068A patent/KR880007568A/ko not_active Ceased
- 1987-12-10 FI FI875427A patent/FI99116C/fi not_active IP Right Cessation
1994
- 1994-06-17 US US08/263,214 patent/US5602010A/en not_active Expired - Fee Related
- 1994-12-12 JP JP6307980A patent/JPH07258294A/ja active Pending
- 1994-12-12 JP JP6307981A patent/JPH07250690A/ja active Pending

Also Published As

Publication number	Publication date
ZA879245B (en)	1989-08-30
IE60404B1 (en)	1994-07-13
EP0271824A2 (de)	1988-06-22
JPS63233794A (ja)	1988-09-29
FI99116C (fi)	1997-10-10
FI875427L (fi)	1988-06-11
AU616873B2 (en)	1991-11-14
KR880007568A (ko)	1988-08-27
NO180239B (no)	1996-12-02
AU8223387A (en)	1988-06-30
PT86332A (de)	1988-01-01
ES2058094T3 (es)	1994-11-01
NO875136D0 (no)	1987-12-09
ATE91722T1 (de)	1993-08-15
JPH07258294A (ja)	1995-10-09
CA1339776C (en)	1998-03-24
JPH07250690A (ja)	1995-10-03
HUT46066A (en)	1988-09-28
EP0271824A3 (en)	1989-05-24
DK645887D0 (da)	1987-12-09
IL84780A (en)	1992-11-15
HU213566B (en)	1997-08-28
DK170054B1 (da)	1995-05-08
IE873342L (en)	1988-06-10
SU1701114A3 (ru)	1991-12-23
NZ222856A (en)	1991-11-26
EP0271824B1 (de)	1993-07-21
FI99116B (fi)	1997-06-30
US5602010A (en)	1997-02-11
IL84780A0 (en)	1988-05-31
DE3642096A1 (de)	1988-06-16
DK645887A (da)	1988-06-11
PH30889A (en)	1997-12-23
NO180239C (no)	1997-03-12
DE3786649D1 (de)	1993-08-26
FI875427A0 (fi)	1987-12-10
PT86332B (pt)	1990-11-07

Publication	Publication Date	Title
ATE91722T1 (de)	1993-08-15	Pferde-gamma-interferon.
DZ467A1 (fr)	2004-09-13	Interferon immunitaire urbain.
DK638887A (da)	1988-06-06	Syntetiske polypeptider og deres anvendelse til diagnosticering
NO863000L (no)	1987-01-28	Fusjonsproteiner og fremgangsmaate til fremstilling derav.
HUT46061A (en)	1988-09-28	Dna sequences encoding hirudin-like protein and process for producing such proteins
DK491487D0 (da)	1987-09-18	Dna-sekvens til ekspressionering af biologisk aktivt faktor xiii og anvendelse af samme
ATE109205T1 (de)	1994-08-15	Verbesserung der ausbeute bei der sekretion von disulfidverbrückten proteinen.
IL81018A (en)	1992-03-29	Fusion proteins comprising small fragments of human interleukin-2 as ballast,process for its preparation and genes,vectors and transformed host containing said fragments and used in the process
DE3881023D1 (de)	1993-06-17	Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
GB2171703B (en)	1989-11-15	Expression-secretion vector for gene expression and protein secretion, recombinant dna including the vector, and method of producing proteins by use of the re
DK27097A (da)	1997-03-13	Minactivin og fremgangsmåde til fremstilling deraf
NO178704C (no)	1996-05-15	DNA-sekvens som koder for protein med IRF-1-aktivitet, ekspresjonsvektor inneholdende denne, anvendelse av IRF-1 for å öke ekspresjon, vertscelle transformert med ekspresjonsvektoren, og protein med IRF-1-aktivitet